Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125449782 | 12544978 | 2 | F | 20160710 | 20160711 | 20160718 | EXP | CA-JNJFOC-20160702567 | JANSSEN | LUPICHUK S, TILLEY D, KOSTARAS X, JOY AA. REAL-WORLD ADJUVANT TAC OR FEC-D FOR HER2-NEGATIVE NODE-POSITIVE BREAST CANCER IN WOMEN LESS THAN 50 YEARS OF AGE. CURRENT ONCOLOGY JUN-2016;23(3):164-169. | 0.00 | A | F | Y | 0.00000 | 20160718 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125449782 | 12544978 | 1 | PS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 6 CYCLES | N | 50718 | LIPOSOME INJECTION | ||||||||
| 125449782 | 12544978 | 2 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | 6 CYCLES | U | 0 | UNSPECIFIED | ||||||||
| 125449782 | 12544978 | 3 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | U | 0 | UNKNOWN | |||||||||
| 125449782 | 12544978 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125449782 | 12544978 | 1 | Breast cancer |
| 125449782 | 12544978 | 2 | Breast cancer |
| 125449782 | 12544978 | 3 | Breast cancer |
| 125449782 | 12544978 | 4 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125449782 | 12544978 | OT |
| 125449782 | 12544978 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125449782 | 12544978 | Adverse event | |
| 125449782 | 12544978 | Diarrhoea | |
| 125449782 | 12544978 | Fatigue | |
| 125449782 | 12544978 | Febrile neutropenia | |
| 125449782 | 12544978 | Gastrooesophageal reflux disease | |
| 125449782 | 12544978 | Hypersensitivity | |
| 125449782 | 12544978 | Infection | |
| 125449782 | 12544978 | Neuropathy peripheral | |
| 125449782 | 12544978 | Oedema | |
| 125449782 | 12544978 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |